Gestion des anticoagulants et des antagonistes

Reversal of antithrombotic agents. (manokatra rohy)

Bauer KA.

Loharanon-kevitra‎: Am J Hematol 2012;87 Suppl 1:S119-26.

Rakitra‎: PubMed 22460529

DOI‎: 10.1002/ajh.23165

https://www.ncbi.nlm.nih.gov/pubmed/22460529 (manokatra rohy)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (manokatra rohy)

Chai-Adisaksopha C, Hillis C, Lim W, Boonyawat K, Moffat K, Crowther M

Loharanon-kevitra‎: J Thromb Haemost 2015;13(10):1790-8.

Rakitra‎: PubMed 26270886

DOI‎: 10.1111/jth.13117

https://www.ncbi.nlm.nih.gov/pubmed/26270886 (manokatra rohy)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (manokatra rohy)

Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr; ANNEXA-4 Investigators

Loharanon-kevitra‎: N Engl J Med 2019;380(14):1326-35.

Rakitra‎: PubMed 30730782

DOI‎: 10.1056/NEJMoa1814051

https://www.ncbi.nlm.nih.gov/pubmed/30730782 (manokatra rohy)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (manokatra rohy)

Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M; ANNEXA-4 Investigators

Loharanon-kevitra‎: N Engl J Med 2016;375(12):1131-41.

Rakitra‎: PubMed 27573206

DOI‎: 10.1056/NEJMoa1607887

https://www.ncbi.nlm.nih.gov/pubmed/27573206 (manokatra rohy)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (manokatra rohy)

Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M

Loharanon-kevitra‎: Circulation 2011;124(14):1573-9.

Rakitra‎: PubMed 21900088

DOI‎: 10.1161/CIRCULATIONAHA.111.029017

https://www.ncbi.nlm.nih.gov/pubmed/21900088 (manokatra rohy)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (manokatra rohy)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Loharanon-kevitra‎: Lancet 2015;385(9982):2077-87.

Rakitra‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (manokatra rohy)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (manokatra rohy)

Gordon JL, Fabian TC, Lee MD, Dugdale M

Loharanon-kevitra‎: J Trauma Acute Care Surg 2013;75(3):475-86.

Rakitra‎: PubMed 24089118

DOI‎: 10.1097/TA.0b013e3182a07391

https://www.ncbi.nlm.nih.gov/pubmed/24089118 (manokatra rohy)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (manokatra rohy)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Loharanon-kevitra‎: Am J Hematol 2012;87 Suppl 1:S141-5.

Rakitra‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (manokatra rohy)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (manokatra rohy)

Levi M, Eerenberg E, Kamphuisen PW.

Loharanon-kevitra‎: J Thromb Haemost 2011;9(9):1705-12.

Rakitra‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (manokatra rohy)

Emergency reversal of warfarin anticoagulation. (manokatra rohy)

Lin Y, Callum J.

Loharanon-kevitra‎: CMAJ 2010;182(18):2004.

Rakitra‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (manokatra rohy)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (manokatra rohy)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

Loharanon-kevitra‎: Thromb Haemost 2012;108(2):217-24.

Rakitra‎: PubMed 22627883

DOI‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (manokatra rohy)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (manokatra rohy)

Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group.

Loharanon-kevitra‎: J Thromb Haemost 2008;6(4):622-31.

Rakitra‎: PubMed 18208533

DOI‎: 10.1111/j.1538-7836.2008.02904.x

https://www.ncbi.nlm.nih.gov/pubmed/18208533 (manokatra rohy)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (manokatra rohy)

Piran S, Khatib R, Schulman S, Majeed A, Holbrook A, Witt DM, Wiercioch W, Schünemann HJ, Nieuwlaat R

Loharanon-kevitra‎: Blood Adv 2019;3(2):158-67.

Rakitra‎: PubMed 30658963

DOI‎: 10.1182/bloodadvances.2018024133

https://www.ncbi.nlm.nih.gov/pubmed/30658963 (manokatra rohy)

Idarucizumab for dabigatran reversal. (manokatra rohy)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

Loharanon-kevitra‎: N Engl J Med 2015;373(6):511-20.

Rakitra‎: PubMed 26095746

DOI‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (manokatra rohy)

Idarucizumab for dabigatran reversal - full cohort analysis. (manokatra rohy)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Loharanon-kevitra‎: N Engl J Med 2017;377(5):431-41.

Rakitra‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (manokatra rohy)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (manokatra rohy)

Reiter RA, Mayr F, Blazicek H, Galehr E, Jilma-Stohlawetz P, Domanovits H, Jilma B

Loharanon-kevitra‎: Blood 2003;102(13):4594-9.

Rakitra‎: PubMed 12920042

DOI‎: 10.1182/blood-2002-11-3566

https://www.ncbi.nlm.nih.gov/pubmed/12920042 (manokatra rohy)

Role of agents for reversing the effects of target-specific oral anticoagulants. (manokatra rohy)

Riley TR, Gauthier-Lewis ML, Sanchez CK, Douglas JS

Loharanon-kevitra‎: Am J Health Syst Pharm 2017;74(2):54-61.

Rakitra‎: PubMed 27895055

DOI‎: 10.2146/ajhp150810

https://www.ncbi.nlm.nih.gov/pubmed/27895055 (manokatra rohy)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (manokatra rohy)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Loharanon-kevitra‎: Anesth Analg 2011;113(4):703-10.

Rakitra‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (manokatra rohy)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (manokatra rohy)

Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Messé SR, Pollack CV Jr, Rodriguez F, Sarode R, Siegal D, Wiggins BS

Loharanon-kevitra‎: J Am Coll Cardiol 2017;70(24):3042-67.

Rakitra‎: PubMed 29203195

DOI‎: 10.1016/j.jacc.2017.09.1085

https://www.ncbi.nlm.nih.gov/pubmed/29203195 (manokatra rohy)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (manokatra rohy)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Loharanon-kevitra‎: World Neurosurg 2014;81(1):110-5.

Rakitra‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (manokatra rohy)

Reversal of warfarin-induced hemorrhage in the emergency department. (manokatra rohy)

Zareh M, Davis A, Henderson S.

Loharanon-kevitra‎: West J Emerg Med 2011;12(4):386-92.

Rakitra‎: PubMed 22224125

DOI‎: 10.5811/westjem.2011.3.2051

https://www.ncbi.nlm.nih.gov/pubmed/22224125 (manokatra rohy)

SOINS INTENSIFS ET RÉANIMATION

Gestion des anticoagulants et des antagonistes

Malagasy

Gestion des anticoagulants et des antagonistes

https://assetsnffrgf-a.akamaihd.net/assets/ct/e781f8601f/images/syn_placeholder_sqr.png

Reversal of antithrombotic agents. (manokatra rohy)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (manokatra rohy)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (manokatra rohy)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (manokatra rohy)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (manokatra rohy)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (manokatra rohy)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (manokatra rohy)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (manokatra rohy)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (manokatra rohy)

Emergency reversal of warfarin anticoagulation. (manokatra rohy)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (manokatra rohy)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (manokatra rohy)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (manokatra rohy)

Idarucizumab for dabigatran reversal. (manokatra rohy)

Idarucizumab for dabigatran reversal - full cohort analysis. (manokatra rohy)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (manokatra rohy)

Role of agents for reversing the effects of target-specific oral anticoagulants. (manokatra rohy)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (manokatra rohy)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (manokatra rohy)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (manokatra rohy)

Reversal of warfarin-induced hemorrhage in the emergency department. (manokatra rohy)

Tompon’andraikitra eo An-toerana

Fanazavana Momba ny Fitsaboana

Video

Gestion des anticoagulants et des antagonistes

Fidio ny Fiteninao

Hizara